Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Hepatology

• Publication date

  2004-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.20152PMID 15057897
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Blood Ammonia Elevation Following Oral Glutamine Load on the Psychometric Performance of Cirrhotic Patients

  2003cited by this paper
• Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy.

  2002cited by this paper
• Survival and Prognostic Indicators in Patients with Hepatitis B Virus–Related Cirrhosis After Onset of Hepatic Decompensation

  2002cited by this paper
• Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS

  2002cited by this paper
• Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients.

  2001cited by this paper
• Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

  2001cited by this paper
• CHRONIC LIVER DISEASES: EPIDEMIOLOGY, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis

  2001cited by this paper
• Effect of l-ornithine-l-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial

  2000cited by this paper
• The prognostic significance of subclinical hepatic encephalopathy

  2000cited by this paper
• Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.

  2000cited by this paper
• Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

  2000cited by this paper
• Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests

  1999cited by this paper
• Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation

  1999cited by this paper
• Prognostic significance of hepatic encephalopathy in patients with cirrhosis.

  1999cited by this paper
• Subclinical hepatic encephalopathy impairs daily functioning

  1998cited by this paper
• Oral glutamine challenge in cirrhotics pre‐ and post‐liver transplantation: A psychometric and analyzed EEG study

  1997cited by this paper
• Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

  1996cited by this paper
• Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis

  1996cited by this paper
• Predictive factors of in‐hospital CNS complications following liver transplantation

  1994cited by this paper
• Neomycin reduces the intestinal production of ammonia from glutamine.

  1994cited by this paper
• Severity of hepatic encephalopathy before liver transplantation is associated with quality of life after transplantation.

  1992cited by this paper
• Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors.

  1989cited by this paper
• The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis.

  1986cited by this paper
• A 20-year prospective study of cirrhosis.

  1981cited by this paper

• Phosphate binders suppress glutaminase activity for treatment of cirrhosis and hepatic encephalopathy murine models.

  2026cites this paper
• Role of ammonia and glutamine in the pathogenesis and progression of metabolic dysfunction‐associated steatotic liver disease: A systematic review

  2024cites this paper
• Covert hepatic encephalopathy is associated with aggressive disease progression and poor survival in patients with cirrhosis

  2023cites this paper
• Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies

  2022cites this paper
• Plasma glutamine status at intensive care unit admission: an independent risk factor for mortality in critical illness

  2021cites this paper
• Identification of patients with and without minimal hepatic encephalopathy based on gray matter volumetry using a support vector machine learning algorithm

  2020cites this paper
• Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice

  2019cites this paper
• Hyperammonemia After Blood Transfusion

  2018cites this paper
• Increasing Incidence of Multiply Recurrent Clostridium difficile Infection

  2018cites this paper
• Hyperammonemia After Blood Transfusion

  2018cites this paper
• Hyperammonemia After Blood Transfusion

  2018cites this paper
• Increasing Incidence of Multiply Recurrent Clostridium difficile Infection

  2018cites this paper
• Increasing Incidence of Multiply Recurrent Clostridium difficile Infection

  2018cites this paper
• Neuropsychiatric performance in patients with cirrhosis: Who is "normal"?

  2017cites this paper
• Hyperammonemia After Blood Transfusion

  2017cites this paper
• The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients

  2017cites this paper
• Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits

  2017cites this paper
• Plasma Glutamine Concentrations in Liver Failure

  2016cites this paper
• Factors contributing to the development of overt encephalopathy in liver cirrhosis patients

  2016cites this paper
• Vigilance and wake EEG architecture in simulated hyperammonaemia: a pilot study on the effects of L-Ornithine-L-Aspartate (LOLA) and caffeine

  2016cites this paper
• Encefalopatía hepática mínima Artículo de revisión

  2016cites this paper
• Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.

  2015cites this paper
• Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non‐inferiority randomized controlled trial

  2015cites this paper
• The Oral Glutamine Challenge in Liver Cirrhosis

  2015cites this paper
• Identification of Minimal Hepatic Encephalopathy in Patients with Cirrhosis Based on White Matter Imaging and Bayesian Data Mining

  2015cites this paper
• Using saccades to diagnose covert hepatic encephalopathy

  2015cites this paper
• Diagnosis and Treatment of Low-Grade Hepatic Encephalopathy

  2015cites this paper
• Hepatic Encephalopathy: From the Pathogenesis to the New Treatments

  2014cites this paper
• APPETITE ASSESSMENT IN CHRONIC LIVER DISEASE PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY

  2014cites this paper
• Aberrant interhemispheric functional coordination in patients with HBV-related cirrhosis and minimal hepatic encephalopathy

  2014cites this paper
• Classification of Cirrhotic Patients with or without Minimal Hepatic Encephalopathy and Healthy Subjects Using Resting-State Attention-Related Network Analysis

  2014cites this paper
• Acute hyperammonaemia induces a sustained decrease in vigilance, which is modulated by caffeine

  2014cites this paper
• Changes of ammonia levels in patients with acute on chronic liver failure treated by plasma exchange.

  2014cites this paper
• Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study

  2013cites this paper
• Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis.

  2013cites this paper
• Brain dysfunction primarily related to previous overt hepatic encephalopathy compared with minimal hepatic encephalopathy: resting-state functional MR imaging demonstration.

  2013cites this paper
• Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis.

  2013cites this paper
• Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy

  2013cites this paper
• Minimal Hepatic Encephalopathy : Standardization of definition and diagnosis

  2013cites this paper
• Czy spektroskopia rezonansu magnetycznego identyfikuje pacjentów z minimaln¹ encefalopati¹ w¹trobow¹?

  2012cites this paper
• Does magnetic resonance spectroscopy identify patients with minimal hepatic encephalopathy?

  2012cites this paper
• Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests

  2012cites this paper
• Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis

  2012influential citation
• Chapter 53 – What Is the Clinical Course of Advanced Liver Disease and What Symptoms Are Associated With It?

  2012cites this paper
• The Rise of Glutaminase in End-Stage Liver Diseases

  2012cites this paper
• Psychometric Hepatic Encephalopathy Score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis

  2012cites this paper
• 638 3-NITRO-TYROSINE AS A PERIPHERAL BIOMARKER OF MINIMAL HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS

  2012cites this paper
• Minimal hepatic encephalopathy.

  2011cites this paper
• Diagnostic approach to persistent hepatic encephalopathy.

  2011cites this paper
• Integrating Palliative Care with Chronic Liver Disease Care

  2011cites this paper
• A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis

  2011cites this paper
• Prognostic Assessment in Patients with Hepatic Encephalopathy

  2011cites this paper
• Prevalence of minimal hepatic encephalopathy in cirrhotic patients.

  2011cites this paper
• Minimal Hepatic Encephalopathy Is Associated With Falls

  2011cites this paper
• New assessment of hepatic encephalopathy.

  2011cites this paper
• 3-Nitro-Tyrosine as a Peripheral Biomarker of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis

  2011cites this paper
• Hepatic Encephalopathy in Our Genes?

  2010cites this paper
• Pharmacotherapy of hepatic encephalopathy in cirrhosis

  2010cites this paper
• Variations in the Promoter Region of the Glutaminase Gene and the Development of Hepatic Encephalopathy in Patients With Cirrhosis

  2010cites this paper
• Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver

  2010cites this paper
• Role of artificial liver support in hepatic encephalopathy

  2009cites this paper
• Encefalopatía hepática mínima: diagnóstico e implicaciones

  2009cites this paper
• Encefalopatía hepática mínima

  2009cites this paper
• Cómo prevenir la encefalopatía hepática

  2009cites this paper
• 30 Management of Hepatic Encephalopathy : Seen and Unseen

  2009cites this paper
• Gut ammonia production and its modulation

  2009cites this paper
• Minimal hepatic encephalopathy

  2009cites this paper
• Nuevos métodos de exploración de la encefalopatía hepática

  2008cites this paper
• Desarrollo y validación de un modelo experimental de encefalopatía hepática en ratas con ascitis. Efectos de la administración de IGF-1 frente a rifaximina en este modelo experimental

  2008cites this paper
• Value of the critical flicker frequency in patients with minimal hepatic encephalopathy

  2007cites this paper
• Minimal hepatic encephalopathy

  2007cites this paper
• Lactulose improves cognitive functions and health‐related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

  2007cites this paper
• Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic encephalopathy.

  2007cites this paper
• Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients

  2007cites this paper
• [Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy].

  2006cites this paper
• [Diagnosis and treatment of hepatic encephalopathy in Spain: results of a survey of hepatologists].

  2006cites this paper
• Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.

  2006cites this paper
• Diagnóstico y tratamiento de la encefalopatía hepática en España: resultados de una encuesta dirigida a hepatólogos

  2006cites this paper
• Avances en la patogenia y el diagnóstico de la encefalopatía hepática

  2006cites this paper
• Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease

  2006cites this paper
• Tablas de normalidad de la población española para los tests psicométricos utilizados en el diagnóstico de la encefalopatía hepática mínima

  2006cites this paper
• HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis

  2005cites this paper
• Role of Phosphate-Activated Glutaminase in the Pathogenesis of Hepatic Encephalopathy

  2005cites this paper